Baker Chad R has filed its latest 13F report, revealing significant investment holdings totaling over $611 million as of September 30, 2026. This filing is crucial as it provides insights into the firm’s investment strategies and highlights its positions in various leading companies across multiple sectors.
As an investment management firm, Baker Chad R is categorized under the 'other' entity type, focusing on managing assets for clients. The firm’s recent filings indicate a consistent approach to investment management, with several 13F-HR submissions over the past year, showcasing its ongoing commitment to transparency and regulatory compliance.
The latest filing, accession number 0001666470-26-000004, was submitted on October 22, 2026. It reports a total of 52 holdings, with a significant portfolio value of $611,541,890. This figure reflects a diverse range of investments, underscoring the firm’s strategic allocation across various industries.
The report includes notable positions in companies such as Abbott Labs, Adobe Systems, and Advanced Micro Devices, among others. For instance, Baker Chad R holds 106,660 shares of Abbott Labs, valued at approximately $10,541,208. Other significant investments include 83,168 shares of Advanced Micro Devices, valued at about $50,878,856, and 9,000 shares of Adobe Systems, worth $2,159,460.
This filing could impact various stakeholders, including clients, investors, and competitors in the asset management industry. With substantial investments in technology and healthcare, Baker Chad R's strategies may influence market trends and investor sentiment in these sectors. Competitors may need to evaluate their own portfolios and strategies in light of Baker Chad R's significant holdings.
The filing does not specify what actions Baker Chad R plans to take next, leaving the market to speculate on potential future moves. However, the firm’s consistent reporting and significant holdings suggest a proactive approach to investment management.